Marianne Kraus
- Hematology top 2%
- Multiple Myeloma Research and Treatments 21
- Virology top 5%
- HIV Research and Treatment 7
- Immunology top 5%
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 24
- Protein Degradation and Inhibitors 11
- Glycosylation and Glycoproteins Research 4
- Oncology top 5%
- Peptidase Inhibition and Analysis 9
-
- HIV/AIDS drug development and treatment 11
-
- Autophagy in Disease and Therapy 5
- Co-authors
- Christoph DriessenHerman S. OverkleeftMichael ReichHubert KalbacherJürgen BaderRainer FischerJens BrandenburgKatharina Kreymborg
- Cited by
- HematologyVirologyImmunology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Angewandte Chemie International Edition (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- SwitzerlandNetherlandsGermany
In The Last Decade
Marianne Kraus
45 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Hematology 614
- Virology 148
- Immunology 441
- Molecular Biology 1.4k
- Oncology 537
Countries citing papers authored by Marianne Kraus
This map shows the geographic impact of Marianne Kraus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marianne Kraus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marianne Kraus more than expected).
Fields of papers citing papers by Marianne Kraus
This network shows the impact of papers produced by Marianne Kraus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marianne Kraus. The network helps show where Marianne Kraus may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marianne Kraus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 5 | |
| 3 | 2019 | 13 | |
| 4 | 2019 | 16 | |
| 5 | 2017 | 1 | |
| 6 | 2017 | 11 | |
| 7 | 2017 | 87 | |
| 8 | 2016 | 106 | |
| 9 | 2015 | 19 | |
| 10 | 2015 | 41 | |
| 11 | 2014 | 0 | |
| 12 | 2013 | 46 | |
| 13 | 2013 | 44 | |
| 14 | 2011 | 329 | |
| 15 | 2009 | 118 | |
| 16 | 2008 | 61 | |
| 17 | 2006 | 70 | |
| 18 | Autophagy promotes MHC class II presentation of peptides from intracellular source proteinsbreakdown → | 2005 | 504 |
| 19 | 2005 | 41 | |
| 20 | 2004 | 29 |
About Marianne Kraus
Marianne Kraus is a scholar working on Hematology, Virology and Infectious Diseases, having authored 48 papers that have together received 2.2k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (24 papers), Multiple Myeloma Research and Treatments (21 papers), Protein Degradation and Inhibitors (11 papers), HIV/AIDS drug development and treatment (11 papers), Peptidase Inhibition and Analysis (9 papers), HIV Research and Treatment (7 papers), Autophagy in Disease and Therapy (5 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Hematology (614 citations), Virology (148 citations) and Immunology (441 citations). Marianne Kraus has collaborated with scholars based in Switzerland, Netherlands and Germany. Frequent co-authors include Christoph Driessen, Herman S. Overkleeft, Michael Reich, Hubert Kalbacher, Jürgen Bader, Rainer Fischer, Jens Brandenburg, Katharina Kreymborg, Florian Altenberend and Margret Müller. Their work appears in journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.